LAU JOHNSON YIU NAM, CEO of ATNX - Past Performance as of 02/22/18. Total 5 Records. Link to Thomson Financial
Buy(P) /
Sell(S)
P/S date Filed Date Company Symbol Insider Relationship Share Amt. Unit Price Total Proceeds Shares Owned Return(1m) Details
P 2018-02-08 2018-02-09 17:22:45 Athenex, Inc. ATNX LAU JOHNSON YIU NAM CEO 20,000 $14.40 $287,906.00 2,767,920 view
P 2017-06-19 2017-06-21 15:17:02 Athenex, Inc. ATNX LAU JOHNSON YIU NAM CEO 25,200 $11.00 $277,200.00 2,747,920 N/A view
P 2012-06-04 2012-06-05 16:56:22 Chelsea Therapeutics International, Ltd. CHTP LAU JOHNSON YIU NAM director 8,000 $1.31 $10,480.00 11,000 -33.59% view
P 2008-10-03 2008-10-03 17:03:38 Chelsea Therapeutics International, Ltd. CHTP LAU JOHNSON YIU NAM director 1,000 $2.76 $2,760.00 3,000 -24.28% view
P 2008-09-29 2008-09-30 10:27:24 Chelsea Therapeutics International, Ltd. CHTP LAU JOHNSON YIU NAM director 2,000 $3.02 $6,040.00 2,000 -43.05% view
* Filed by insider as open market transaction, but marked as private transaction by insidercow's proprietary method